6383.T (6383.T)

$2.16T
Market Cap
29.0
P/E Ratio
0.81
Beta
1.45%
Dividend Yield
Piotroski 8/9Altman Z 6.9 SafeROIC−WACC +6.8%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 6.9 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates robust fundamental quality, evidenced by a 16.5% ROIC that comfortably exceeds the 9.7% WACC, generating a +6.8% spread indicative of strong value creation potential relative to cost of equity. This profitability is driven primarily by operational leverage rather than balance sheet magnification or margin compression, as an 11.8% net margin and 24.5% gross margin underpin earnings quality while revenue expands at an 8.1% annualized rate. Credit risk metrics further validate this structural strength; a Piotroski F-Score of 8/9 signals consistent financial improvement across nine dimensions, while an Altman Z-Score of 6.9 places the entity in a very safe zone with negligible distress probability, suggesting stable cash flow generation and low default risk absent external leverage data.

Valuation metrics present a divergence between current market pricing and historical or sector-relative norms, as the 29.0x P/E multiple implies significant growth expectations are already embedded within share prices. While specific DCF fair value calculations cannot be executed without explicit discount rate assumptions beyond the provided WACC or terminal growth inputs, the premium valuation suggests the market is pricing in a realization of the underlying +6.8% ROIC-WACC spread over an extended horizon. If future revenue expansion falters below current 8.1% trajectories or if margin compression occurs, the multiple could contract sharply given the limited safety cushion provided by such high relative valuations compared to typical growth benchmarks.

Risk assessment relies heavily on the absence of sector-specific Fama-French alpha data and insider transaction records in the available dataset, preventing a definitive synthesis of momentum risks or governance signals. The combination of an 8/9 Piotroski score and low distress probability indicates resilience against downside volatility, yet the high P/E leaves little room for error regarding growth sustainability. Investors must weigh whether the current multiple adequately compensates for the uncertainty surrounding future revenue acceleration versus the defensive characteristics highlighted by strong credit metrics.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
6.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

24.5%
Gross Margin
11.8%
Net Margin
16.5%
ROIC
9.7%
WACC
ROIC − WACC Spread: +6.8%— Positive value creation spread.
+8.1%
Revenue Growth (YoY)
+71.8%
Earnings Growth (YoY)

Balance Sheet Health

0.67x
Debt / Equity
2.57x
Current Ratio
399.5x
Interest Coverage
-1.7x
Net Debt / EBITDA
118.6B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $47.24
Act: $45.86
-2.9%
Q3
✓ Beat
Est: $42.63
Act: $56.46
+32.4%
Q2
✓ Beat
Est: $43.13
Act: $56.69
+31.4%
Q1
✓ Beat
Est: $51.98
Act: $53.38
+2.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

40.8
Forward P/E
PEG Ratio
4.77
Price/Book
2M
Avg Volume
$6516.00
52W High
$3150.00
52W Low
52W Range Position

Compare 6383.T to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.